CLINICAL_TRIALS
trial_result
· 2020-09-03
Clinical Trial Update: A Placebo Controlled, Randomized, Double Blind Trial of Milnacipran for the Treatment of Idiopathic Neuropathy Pain [Phase 3]
Summary
Phase 3 randomized, placebo-controlled trial of milnacipran for idiopathic peripheral neuropathy pain; study terminated with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Columbia University | Conditions: Idiopathic Peripheral Neuropathy | Phase 3 | Status: TERMINATED | Results posted: 2020-09-03